Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112146015 | 11214601 | 5 | F | 201408 | 20160627 | 20150624 | 20160701 | EXP | PHHY2014CA011663 | NOVARTIS | 50.34 | YR | F | Y | 0.00000 | 20160701 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112146015 | 11214601 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | U | 21008 | 30 | MG | /month | ||||||
| 112146015 | 11214601 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 50 UG, ONCE/SINGLE | 0 | 50 | UG | 1X |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112146015 | 11214601 | 1 | Neuroendocrine tumour |
| 112146015 | 11214601 | 2 | Neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112146015 | 11214601 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112146015 | 11214601 | Abdominal pain | |
| 112146015 | 11214601 | Abdominal pain lower | |
| 112146015 | 11214601 | Abdominal pain upper | |
| 112146015 | 11214601 | Back pain | |
| 112146015 | 11214601 | Blood pressure increased | |
| 112146015 | 11214601 | Blood pressure systolic increased | |
| 112146015 | 11214601 | Body temperature decreased | |
| 112146015 | 11214601 | Fatigue | |
| 112146015 | 11214601 | Feeling abnormal | |
| 112146015 | 11214601 | Large intestine polyp | |
| 112146015 | 11214601 | Malaise | |
| 112146015 | 11214601 | Malignant neoplasm progression | |
| 112146015 | 11214601 | Musculoskeletal chest pain | |
| 112146015 | 11214601 | Pain | |
| 112146015 | 11214601 | Rib synostosis | |
| 112146015 | 11214601 | Spinal compression fracture | |
| 112146015 | 11214601 | Spinal cord neoplasm | |
| 112146015 | 11214601 | Tumour pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112146015 | 11214601 | 1 | 20130926 | 0 | ||
| 112146015 | 11214601 | 2 | 20130919 | 20130919 | 0 |